Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Blame men for political gridlock, study says

  • Complex environments push 'brain' evolution

  • Heavy drinking in middle-age may increase stroke risk more than traditional factors

  • FDA approves first-of-kind device to treat obesity

  • Many religious people view science favorably, but reject certain scientific theories

  • Privacy challenges: Just four vague pieces of info can identify you, and your credit card

  • Is this the year you join the top one percent? Affluence more fluid than once thought

  • Infants create new knowledge while sleeping

  • Common pesticide may increase risk of ADHD

  • Walking on ice takes more than brains: 'Mini-brain' in spinal cord aids in balance

  •